| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 08/07/2013 | EP2622090A1 Methods and compositions for inhibiting viral entry into cells |
| 08/07/2013 | EP2622088A2 Mannosidases capable of uncapping mannose-1-phospho-6-mannose linkages and demannosylating phosphorylated n-glycans and methods of facilitating mammalian cellular uptake of glycoproteins |
| 08/07/2013 | EP2622071A1 Polypeptides having endopeptidase activity and polynucleotides encoding same |
| 08/07/2013 | EP2621950A2 Antibodies binding human collagen ii |
| 08/07/2013 | EP2621525A2 Flavivirus domain iii vaccine |
| 08/07/2013 | CN1869217B Method for producing transgene protein medicine of mammary gland expression using gland virus as carrier mammary |
| 08/07/2013 | CN103233054A Method for continuously preparing silkworm chrysalis protein antioxidant peptides by using enzyme membrane reactor |
| 08/07/2013 | CN103233053A Production method for recombinant human granulocyte colony-stimulating factor |
| 08/07/2013 | CN103233019A Genetically engineered bacterium for efficiently expressing recombinant bacteriocin and construction method and application thereof |
| 08/07/2013 | CN103233013A Nile tilapia transforming growth factor TGF-beta 1 gene, related protein and application |
| 08/07/2013 | CN103232963A Collagenase producing strain |
| 08/07/2013 | CN103232961A Uvioresistant bacillus thuringiensis strain and building method and application thereof |
| 08/07/2013 | CN103232545A Recombination porcine interferon alpha1-Fc fusion protein as well as coding gene and expression method thereof |
| 08/07/2013 | CN103232544A Recombination porcine interferon gamma-Fc fusion protein as well as coding gene and expression method thereof |
| 08/07/2013 | CN103232539A Antibodies to opgl |
| 08/07/2013 | CN103232528A Bioactive polypeptide DELQ and preparation method and application thereof |
| 08/07/2013 | CN103232527A Bioactive polypeptide SLPQ and its preparation method and use |
| 08/07/2013 | CN103232526A Bioactive polypeptide LPLP, and preparation and application thereof |
| 08/07/2013 | CN102505034B Method for preparing active polypeptide from corn protein powder |
| 08/07/2013 | CN102443594B Receptor activator of nuclear factor kappa B ligand (RANKL)-HBaAg expression constructing object, yeast, manufacture method as well as application |
| 08/07/2013 | CN102212598B Method for preparing quaternary ammonium hydrolysis wheat peptide concentrated solution from gluten |
| 08/07/2013 | CN101910403B Methods and compositions |
| 08/07/2013 | CN101503697B Preparation of recombinant protein of human vascular endothelial cell growth inhibition factor rhVEGI-192A |
| 08/07/2013 | CN101379089B Anti-ilt7 antibody |
| 08/06/2013 | US8502018 Methods of modifying eukaryotic cells |
| 08/06/2013 | US8502014 Method for the production of a single heavy chain antibody |
| 08/06/2013 | US8501914 Recombinant protein S composition |
| 08/06/2013 | US8501913 Spider mite silk proteins |
| 08/06/2013 | US8501685 Process for preparing peptide products for promoting cholecystokinin secretion and use of the peptide products |
| 08/06/2013 | US8501464 Lentiviral vectors carrying synthetic bi-directional promoters and uses thereof |
| 08/06/2013 | US8501449 Recombinant elastase proteins and methods of manufacturing and use thereof |
| 08/06/2013 | US8501448 Family 44 xyloglucanases |
| 08/06/2013 | US8501439 Method for obtaining active pro-NGF and beta-NGF |
| 08/06/2013 | US8501438 Production of glycoproteins with reduced O-glycosylation |
| 08/06/2013 | US8501427 Factor H polymorphisms in the diagnosis and therapy of inflammatory diseases such as age-related macular degeneration |
| 08/06/2013 | US8501191 FGFR2-IIIb fusion proteins and methods of making them |
| 08/06/2013 | US8501184 High affinity human antibodies to PCSK9 |
| 08/06/2013 | CA2666317C Glycolysis-inhibiting substances in cell culture |
| 08/06/2013 | CA2434414C Polypeptide having .alpha.-isomaltosylglucosaccharide-forming enzyme activity |
| 08/06/2013 | CA2371929C Fab'-epitope complex from the hiv-1 cross-neutralizing monoclonal antibody 2f5 |
| 08/06/2013 | CA2358385C Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 08/01/2013 | WO2013113008A1 Growth differentiation factor 15 (gdf-15) polypeptides |
| 08/01/2013 | WO2013112945A1 Humanized antibodies that recognize alpha-synuclein |
| 08/01/2013 | WO2013112070A1 Method for increasing the effectiveness of synthesizing end products using cell cultures |
| 08/01/2013 | WO2013111754A1 Expression vector and method for producing protein |
| 08/01/2013 | WO2013068602A3 Method for the production of polypeptides |
| 08/01/2013 | WO2012064733A3 Antibody scaffold for homogenous conjugation |
| 08/01/2013 | US20130197214 Nanoparticle chains and Preparation Thereof |
| 08/01/2013 | US20130196427 Cancer antigen peptides derived from wt1 |
| 08/01/2013 | US20130196412 Magi polynucleotides, polypetides, and antibodies |
| 08/01/2013 | US20130196380 In vitro process for the preparation of antibodies of the igg type |
| 08/01/2013 | US20130196376 Method for the High Level Expression of Active Lymphotoxin-Beta Receptor Immunoglobulin Chimeric Proteins and Their Purification |
| 08/01/2013 | US20130196375 Biopharmaceutical process apparatuses assembled into a column |
| 08/01/2013 | US20130196374 Cis-acting element and use thereof |
| 08/01/2013 | US20130196372 Device and method for cell free analytical and preparative protein synthesis |
| 08/01/2013 | US20130195835 Glycosylation of Molecules |
| 08/01/2013 | US20130195829 Themostable Phytase Variants |
| 08/01/2013 | DE102012201297A1 Expressionsverfahren Expression methods |
| 08/01/2013 | CA2856443A1 Vaccines against clostridium difficile comprising recombinant toxins |
| 07/31/2013 | EP2619306A1 Surface display of polypeptides containing a metal porphyrin or a flavin |
| 07/31/2013 | EP2619305A1 Methods for incorporating unnatural amino acids in eukaryotic cells |
| 07/31/2013 | EP1476185B1 Antibodies to cd40 |
| 07/31/2013 | CN103228792A PEG-interferon lambda 1 conjugates |
| 07/31/2013 | CN103228673A Anti-human trop- antibody having antitumor activity in vivo |
| 07/31/2013 | CN103228670A Cry1I proteins and genes for insect control |
| 07/31/2013 | CN103224973A Method of fementing shrimp heads to prepare active substances, chitin and organic acidity calcium |
| 07/31/2013 | CN103224971A Fish skin collagen deodorizing production method |
| 07/31/2013 | CN103224970A Feeding plant protein peptide preparation method |
| 07/31/2013 | CN103224969A Preparation technology of egg white powder glycopeptide |
| 07/31/2013 | CN103224952A Human interleukin29 mature peptide mutant (hIL-29Z) with arginine and lysine produced respectively by site-directed mutagenesis of 33th lysine and 35th arginine and preparation method thereof |
| 07/31/2013 | CN103224951A Human interleukin29 mature peptide mutant (hIL-29G) with lysine produced by site-directed mutagenesis of 35th arginine and preparation method thereof |
| 07/31/2013 | CN103224901A ptsG gene knocked out recombination bacterial efficiently expressing human-like collagen protein, construction method thereof, and protein expression |
| 07/31/2013 | CN103224898A Marine bacillus and its polypeptide with antitumor activity |
| 07/31/2013 | CN103224562A Epitope regions of a thyrotrophin (TSH) receptor, and antibodies thereto |
| 07/31/2013 | CN102701507B Method for treating high-concentration wastewater of glutamic acid |
| 07/31/2013 | CN102618614B Method for preparing urechis unicinctus glycosaminoglycan and antibacterial peptide simultaneously |
| 07/31/2013 | CN102533913B Method for preparing antioxidant active peptide by hydrolyzing fish scale collagen with co-immobilized double enzymes |
| 07/31/2013 | CN102260346B Exendin-4 analog |
| 07/31/2013 | CN101962647B Biosynthesis gene cluster of Nocathiacins and application thereof |
| 07/31/2013 | CN101906455B Preparation method of egg white protein assistant antihypertensive peptides |
| 07/31/2013 | CN101730739B Engineered versions of polysialyltransferases with enhanced enzymatic properties and uses thereof |
| 07/31/2013 | CN101679498B Bis-met histones |
| 07/31/2013 | CN101294187B Method for sustained-releasing polypeptide with biological activity and application thereof |
| 07/31/2013 | CN101225102B Method for preparing tilapia fishskin polypeptide chelate zinc salt |
| 07/30/2013 | US8497355 Anti-glypican-3 antibody having improved kinetics in plasma |
| 07/30/2013 | US8497354 Antibodies to endoplasmin and their use |
| 07/30/2013 | US8497246 Using blood brain barrier receptor specific immunoglobullin as diagnostic and therapeutic for prevention, detection treatment of brain disorders |
| 07/30/2013 | US8497115 Methods for producing secreted polypeptides |
| 07/30/2013 | US8497110 Thermophilic and thermoacidophilic biopolymer-degrading genes and enzymes from alicyclobacillus acidocaldarius and related organisms, methods |
| 07/30/2013 | US8497109 Polypeptides having cellobiohydrolase II activity and polynucleotides encoding same |
| 07/30/2013 | US8497096 Methods and materials for increasing expression of recombinant polypeptides |
| 07/30/2013 | US8497095 Biochemical markers for acute pulmonary embolism |
| 07/30/2013 | US8497094 Prevention and treatment of complement-associated eye conditions |
| 07/30/2013 | US8497093 Leafhopper ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 07/30/2013 | CA2704083C Pigment epithelium-derived factor: characterization, genomic organization and sequence of the pedf gene |
| 07/30/2013 | CA2605671C Magnetic particles with a glass surface and their use |
| 07/30/2013 | CA2545693C Modification of protein glycosylation in methylotrophic yeast |
| 07/30/2013 | CA2540138C Recombinant antibody against human insulin-like growth factor |
| 07/30/2013 | CA2523101C Cleavage of fusion proteins using granzyme b protease |
| 07/30/2013 | CA2521490C Production of recombinant igm in per.c6 cells |